Frugoni P, Pike S E, Tosato G
Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland 20892.
Cell Immunol. 1993 Apr 1;147(2):256-66. doi: 10.1006/cimm.1993.1067.
The tumorigenic potential of B lymphocytes latently infected with EBV is effectively controlled by T cell immunity. The mechanisms of this T cell regulation, however, are incompletely understood. In this study, T lymphocytes were found to proliferate in response to serum-free supernatants of EBV-immortalized cells and to deplete them of growth factors required by the immortalized B cells for autocrine growth. Lactic acid was reported to account for approximately 90% of the autocrine growth factor activity in serum-free supernatants of EBV-immortalized cell lines. Synthetic lactic acid was now found to promote growth in activated T cells. In addition, B cell suppression resulting from coculture of EBV-infected B cells with autologous T cells was reversed by the addition of supernatants from EBV-immortalized cell lines. Thus, T cell competition for growth factors produced and utilized by EBV-immortalized B cells for continuous proliferation may represent an important and novel regulatory mechanism for the maintenance of EBV latency in B lymphocytes.
被EBV潜伏感染的B淋巴细胞的致瘤潜力受到T细胞免疫的有效控制。然而,这种T细胞调节的机制尚未完全明确。在本研究中,发现T淋巴细胞会对EBV永生化细胞的无血清上清液产生增殖反应,并耗尽永生化B细胞自分泌生长所需的生长因子。据报道,乳酸约占EBV永生化细胞系无血清上清液中自分泌生长因子活性的90%。现已发现合成乳酸可促进活化T细胞的生长。此外,将EBV感染的B细胞与自体T细胞共培养所导致的B细胞抑制,可通过添加EBV永生化细胞系的上清液而逆转。因此,T细胞对EBV永生化B细胞产生并用于持续增殖的生长因子的竞争,可能是维持B淋巴细胞中EBV潜伏状态的一种重要且新颖的调节机制。